- Home
- FSEA vs KRON Comparison
FSEA vs KRON Comparison
Compare FSEA & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- KRON
- Stock Information
- Founded
- FSEA 1890
- KRON 2017
- Country
- FSEA United States
- KRON United States
- Employees
- FSEA N/A
- KRON N/A
- Industry
- FSEA Savings Institutions
- KRON Medicinal Chemicals and Botanical Products
- Sector
- FSEA Finance
- KRON Health Care
- Exchange
- FSEA Nasdaq
- KRON Nasdaq
- Market Cap
- FSEA 44.2M
- KRON 60.3M
- IPO Year
- FSEA N/A
- KRON 2020
- Fundamental
- Price
- FSEA $9.15
- KRON $0.93
- Analyst Decision
- FSEA
- KRON Strong Buy
- Analyst Count
- FSEA 0
- KRON 2
- Target Price
- FSEA N/A
- KRON $4.13
- AVG Volume (30 Days)
- FSEA 9.0K
- KRON 59.4K
- Earning Date
- FSEA 11-07-2024
- KRON 11-11-2024
- Dividend Yield
- FSEA N/A
- KRON N/A
- EPS Growth
- FSEA N/A
- KRON N/A
- EPS
- FSEA N/A
- KRON N/A
- Revenue
- FSEA $10,821,000.00
- KRON $8,412,000.00
- Revenue This Year
- FSEA N/A
- KRON $52.58
- Revenue Next Year
- FSEA N/A
- KRON N/A
- P/E Ratio
- FSEA N/A
- KRON N/A
- Revenue Growth
- FSEA N/A
- KRON 172.76
- 52 Week Low
- FSEA $6.25
- KRON $0.69
- 52 Week High
- FSEA $9.49
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- FSEA 53.48
- KRON 44.01
- Support Level
- FSEA $8.98
- KRON $0.85
- Resistance Level
- FSEA $9.23
- KRON $0.97
- Average True Range (ATR)
- FSEA 0.08
- KRON 0.06
- MACD
- FSEA 0.02
- KRON -0.00
- Stochastic Oscillator
- FSEA 71.43
- KRON 43.82
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.